Search results for "Relative risk"

showing 10 items of 303 documents

Neuroticism, extraversion, stressful life events and asthma: a cohort study of middle-aged adults

2009

ABSTRACT Background: Stressful life events can trigger asthma exacerbations, but could also contribute to the development of incident asthma. However, only few studies have investigated the association between stressful life events and adult asthma prospectively. Likewise, stress-related personality traits (e.g. neuroticism and extraversion) may increase asthma risk, but this has been examined in only one prospective study. We therefore aimed to investigate the association between neuroticism, extraversion, stressful life events and incident asthma. Methods: A population-based sample of 5114 middle-aged adults completed questionnaires between 1992 and 1995. Among those alive in 2002/2003, 4…

AdultMalemedicine.medical_specialtyRMNeurotic DisordersPersonality InventoryImmunologyPopulationCohort StudiesExtraversion PsychologicalLife Change Eventssymbols.namesakeRisk FactorsSurveys and QuestionnairesmedicineHumansImmunology and AllergyPoisson regressionBig Five personality traitseducationAgedAsthmaeducation.field_of_studyExtraversion and introversionbusiness.industryMiddle Agedmedicine.diseaseNeuroticismR1AsthmaSurgeryRelative risksymbolsFemalebusinessStress PsychologicalDemographyCohort study
researchProduct

Total body skin examination for skin cancer screening in patients with focused complaints

2012

Background. The value of total body skin examination (TBSE) for skin cancer screening is controversial. Objective: We sought to determine whether TBSE could be helpful in patients with focused skin symptoms who would not otherwise have undergone TBSE. Methods: In a prospective, multicenter, cross-sectional study consecutive adult patients were recruited during a period of 18 months. Physicians first inspected, problem areas and uncovered areas and then performed TBSE. Equivocal lesions detected in both steps were excised or biopsied. Primary outcomes were the absolute and relative risks of missing skin cancer and the number of patients needed to examine to detect melanoma or another maligna…

AdultMalemedicine.medical_specialtySkin NeoplasmsBiopsyprevalenceDermoscopyPhysical examinationDermatologydermatoscopyMalignancySkin Diseasesskin cancer; dermoscopy; prevention; prevalencetotal body skin examinationpreventionAdult; Aged; Biopsy; Cross-Sectional Studies; Dermoscopy; Early Detection of Cancer; Female; Humans; Male; Middle Aged; Physical Examination; Prospective Studies; Skin Diseases; Skin NeoplasmsBiopsymedicinemelanomaHumansProspective StudiesProspective cohort studyPhysical ExaminationEarly Detection of CancerAgedCross-Sectional StudieDermatoscopyintegumentary systemmedicine.diagnostic_testskin cancerbusiness.industrySkin DiseaseMelanomascreeningpigmented skin lesionsMiddle Agedmedicine.diseaseDermatologyProspective StudieCross-Sectional Studiestotal body skin examination; melanoma; skin cancer; preventionRelative riskFemalenonmelanoma skin cancerdermoscopySkin cancerbusinessHuman
researchProduct

Predicting Early and Sustained Virological Responses in Prior Nonresponders to Pegylated Interferon alpha-2b Plus Ribavirin Retreated With Peginterfe…

2013

GOALS: To evaluate the predictive value of complete early virological response (cEVR) on sustained virological response (SVR) following retreatment with peginterferon alpha-2a (40 kDa) plus ribavirin in previous nonresponders to peginterferon alpha-2b (12 kDa). BACKGROUND: In the randomized multinational retreatment with Pegasys in patients not responding to PegIntron therapy study, a 72-week regimen of peginterferon alpha-2a (40 kDa) plus ribavirin improved SVR rates over a standard 48-week regimen in previous nonresponders to peginterferon alpha-2b (12 kDa). cEVR, defined as hepatitis C virus RNA <50 IU/mL at treatment week 12, was an important predictor of SVR. STUDY: We conducted an exp…

AdultMalemedicine.medical_specialtyTime FactorsInterferon alpha-2Antiviral therapyAntiviral AgentsGastroenterologyPolyethylene Glycolslaw.inventionchemistry.chemical_compoundPharmacotherapyRandomized controlled trialnonresponderPredictive Value of TestslawInternal medicineRibavirinchronic hepatitis CHumansMedicinepeginterferonAdverse effectRandomized Controlled Trials as Topicbusiness.industryRibavirinGastroenterologyInterferon-alphavirus diseasesHepatitis CHepatitis C ChronicMiddle Agedmedicine.diseasepeginterferon; chronic hepatitis C; nonresponder; retreatment; sustained virological responseRecombinant Proteinsdigestive system diseasesRegimenTreatment OutcomechemistryPredictive value of testsRelative riskRetreatmentDrug Therapy CombinationFemalesustained virological responsebusinessJournal of Clinical Gastroenterology
researchProduct

Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.

2011

Abstract The safest duration of anticoagulation after idiopathic deep vein thrombosis (DVT) is unknown. We conducted a prospective study to assess the optimal duration of vitamin K antagonist (VKA) therapy considering the risk of recurrence of thrombosis according to residual vein thrombosis (RVT). Patients with a first unprovoked DVT were evaluated for the presence of RVT after 3 months of VKA administration; those without RVT suspended VKA, while those with RVT continued oral anticoagulation for up to 2 years. Recurrent thrombosis and/or bleeding events were recorded during treatment (RVT group) and 1 year after VKA withdrawal (both groups). Among 409 patients evaluated for unprovoked DVT…

AdultMalemedicine.medical_specialtyVitamin Kmedicine.drug_classDeep veinHemorrhageDrug Administration ScheduleSettore MED/15 - Malattie Del SangueRecurrenceRisk Factorsdeep vein thrombosis (DVT)Residual vein thrombosismedicineHumansProspective Studiesdeep vein thrombosis (DVT); vitamin K antagonist (VKA) therapy; Residual vein thrombosisProspective cohort studyAgedUltrasonographyVenous Thrombosisbusiness.industryAcenocoumarolAnticoagulantsHematologyVenous ThromboembolismVitamin K antagonistMiddle Agedmedicine.diseaseThrombosisConfidence intervalSurgeryClinical trialVein thrombosisvitamin K antagonist (VKA) therapymedicine.anatomical_structureLower ExtremityRelative riskFemaleWarfarinbusiness
researchProduct

Long-term population-based risks of breast cancer after childhood cancer

2008

Previous studies have reported substantially increased risks of breast cancer among survivors of childhood cancer at 10–20 years posttreatment. Whether these excess risks are sustained beyond 40 years of age when general population incidence of breast cancer begins its steep increase is largely unknown. We quantified the risk of breast cancer in adult female survivors with considerably more survivors followed-up beyond 40 years of age than previously available. Standardized Incidence Ratios (SIR), Excess Absolute Risks (EAR), and cumulative incidence were calculated within a population-based cohort of 8,093 female survivors of childhood cancer. Poisson regression models were used to model S…

AdultRiskCancer Researchmedicine.medical_specialtyPopulationBreast NeoplasmsCohort StudiesBreast cancermedicineHumansCumulative incidenceSurvivorsRisk factorChildeducationAgededucation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)CancerNeoplasms Second PrimaryMiddle Agedmedicine.diseaseSurgeryOncologyRelative riskMultivariate AnalysisFemaleBreast diseasebusinessSEER ProgramDemographyInternational Journal of Cancer
researchProduct

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer

1997

Background: Major risk factors for invasive cervical cancer include infection with human papillomavirus (HPV), infection with other sexually transmitted pathogens (e.g., Chlamydia trachomatis), and smoking. Since exposures to these risk factors can be related, the contribution of any single factor to cervical carcinogenesis has been difficult to assess. We conducted a prospective study to define the role of HPV infection in cervical carcinogenesis, with invasive cancer as an end point. Methods: A nested case‐control study within a joint cohort of 700 000 Nordic subjects was performed. The 182 women who developed invasive cervical cancer during a mean follow-up of 5 years were matched with 5…

AdultRiskCancer Researchmedicine.medical_specialtyRadioimmunoassaySexually Transmitted DiseasesUterine Cervical NeoplasmsAdenocarcinomamedicine.disease_causeSerology03 medical and health sciences0302 clinical medicineRisk FactorsSeroepidemiologic StudiesInternal medicinePrevalencemedicineHumansNeoplasm InvasivenessProspective Studies030212 general & internal medicinePapillomaviridaeRisk factorPapillomaviridaeGynecologyCervical cancerbiologybusiness.industryIncidencePapillomavirus InfectionsHPV infectionCancerMiddle Agedbiology.organism_classificationmedicine.disease3. Good healthTumor Virus InfectionsOncologyCase-Control Studies030220 oncology & carcinogenesisRelative riskCarcinoma Squamous CellFemalebusinessChlamydia trachomatis
researchProduct

Hormonal contraceptives and breast cancer: Clinical data.

2018

Abstract The endocrine background of breast cancer has raised questions about the increase in risk that might bear the use of hormonal contraceptives. This has been a particular issue in the case of young women, who constitute the population of contraceptive consumers. Observational studies have been the main source of evidence, which has mainly limited to the combined estrogen-progestogen preparations, the popular pill. Studies in the 80′s and 90′s of the past century found a small, around a 20%, increase in risk. The translation in absolute number of excess cases has been exiguous because the prevalence of the disease is relatively small in premenopausal women. Moreover, the risk slowly s…

AdultTime Factorsmedicine.medical_treatmentPopulationGenes BRCA2Genes BRCA1PhysiologyBreast NeoplasmsDiseaseContraceptives Oral Hormonal03 medical and health sciencesYoung Adult0302 clinical medicineBreast cancerRisk FactorsmedicineEndocrine systemHumanseducationeducation.field_of_study030219 obstetrics & reproductive medicineProgestogenbusiness.industryObstetrics and GynecologyCancermedicine.diseaseReproductive Medicine030220 oncology & carcinogenesisPillRelative riskMutationFemalebusinessEuropean journal of obstetrics, gynecology, and reproductive biology
researchProduct

The Association of Mediterranean Diet during Pregnancy with Longitudinal Body Mass Index Trajectories and Cardiometabolic Risk in Early Childhood.

2019

Objective To evaluate the associations between maternal adherence to the Mediterranean diet during pregnancy and their offspring's longitudinal body mass index (BMI) trajectories and cardiometabolic risk in early childhood. Study design We included mother-child pairs from the Infancia y Medio Ambiente (INMA) longitudinal cohort study in Spain. We measured dietary intake during pregnancy using a validated food frequency questionnaire and calculated the relative Mediterranean diet score (rMED). We estimated offspring's BMI z score trajectories from birth to age 4 years using latent class growth analyses (n = 2195 mother-child pairs). We measured blood pressure, waist circumference, and cardio…

AdultWaistMediterranean dietOffspringBlood PressureLower riskDiet MediterraneanBody Mass Index03 medical and health sciences0302 clinical medicinePregnancyRisk Factors030225 pediatricsMedicineHumans030212 general & internal medicineLongitudinal StudiesChildPregnancybusiness.industrymedicine.diseaseCardiovascular DiseasesSpainRelative riskChild PreschoolPediatrics Perinatology and Child HealthCohortFemaleWaist CircumferencebusinessBody mass indexDemographyThe Journal of pediatrics
researchProduct

Effect of Breast Cancer Treatment on Dietary Vitamin Intake Levels

2020

Breast cancer is the most common tumor among women, representing the second cause of cancer deaths in women. Treatment with chemotherapy negatively interferes with nutritional status. The intake of vitamins before, during and after treatment in a pilot cohort of women with non-invasive breast cancer (type I, II) treated at the Valencian Institute of Oncology (IVO) is evaluated. A 3-day anthropometric and nutritional assessment was performed using the DIAL program. Nutritional intake is compared with the values of Estimated Average Requirements (EAR) and Dietary Reference Intake (DRI) provided by the United States Department of Agriculture (USDA) and the European Food Safety Authority (EFSA)…

Adultmedicine.medical_specialty030309 nutrition & dieteticsHealth Toxicology and Mutagenesislcsh:MedicineNutritional StatusBreast NeoplasmsPilot ProjectsArticleCohort Studies03 medical and health sciences0302 clinical medicineBreast cancerbreast cancerInternal medicineEpidemiologymedicineHumans0303 health sciencesbusiness.industrylcsh:RPublic Health Environmental and Occupational HealthCancerVitaminsAnthropometryMiddle Agedmedicine.diseaseMicronutrientUnited StatesDietDietary Reference IntakeSpain030220 oncology & carcinogenesisRelative riskmicronutrientsCohortFemaleepidemiologybusinessdietInternational Journal of Environmental Research and Public Health
researchProduct

Effect of per Capita Income on the Relationship between Periodontal Disease during Pregnancy and the Risk of Preterm Birth and Low Birth Weight Newbo…

2020

This work analyzed the available evidence in the scientific literature about the risk of preterm birth and/or giving birth to low birth weight newborns in pregnant women with periodontal disease. A systematic search was carried out in three databases for observational cohort studies that related periodontal disease in pregnant women with the risk of preterm delivery and/or low birth weight, and that gave their results in relative risk (RR) values. Eleven articles were found, meeting the inclusion criteria. Statistically significant values were obtained regarding the risk of preterm birth in pregnant women with periodontitis (RR = 1.67 (1.17–2.38), 95% confidence interval (CI)), and low birt…

Adultmedicine.medical_specialtyAdolescentHealth Toxicology and Mutagenesisperiodontal diseaselcsh:MedicineReviewYoung Adult03 medical and health sciences0302 clinical medicinePregnancyHumansChildbirthMedicinelow birth weight030212 general & internal medicineRisk factorPeriodontitisPeriodontal DiseasesPregnancybusiness.industryObstetricslcsh:RInfant NewbornPublic Health Environmental and Occupational Health030206 dentistryInfant Low Birth Weightpremature birthmedicine.diseaseConfidence intervalincome levelPregnancy Complicationsmeta-analysisLow birth weightrisk factorPremature birthRelative riskIncomeFemalemedicine.symptombusinessCohort studyInternational Journal of Environmental Research and Public Health
researchProduct